1 tracked superinvestor hold DAMORA THERAPEUTICS INC (DMRA), worth $60M combined, led by Andreas Halvorsen. Smart money is holding DMRA as of the latest 13F filings.
Current price
$30.06
+902.0%
1Y
Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jörgen Nilsson, Hakon…
Market cap
$1.5B
P/E
-6.37
Div yield
0.0%
Revenue YoY
0.0%
Analyst target
$44
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
1
tracked 13F / N-PORT funds
Combined value
$60M
disclosed long exposure
Tier-1 conviction
1
concentrated holders
Net this quarter
0
0 buying · 0 selling
Smart money is holding DMRA steady this quarter — buys and sells are balanced.
DAMORA THERAPEUTICS INC (DMRA) is held by 1 tracked funds worth $60M combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.
The largest position belongs to Andreas Halvorsen at 0.2% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
Tracked holders were largely static this quarter — no new opens, adds or trims of size — suggesting the position is being held rather than actively traded.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| Held | 0.2% | $60M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own DMRA?
1 tracked funds hold DAMORA THERAPEUTICS INC (DMRA), the largest being Andreas Halvorsen (Viking Global Investors) at 0.2% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling DMRA?
In the most recent 13F quarter, 0 tracked funds added or opened DMRA and 0 trimmed it.
How much DMRA do tracked funds hold?
Combined disclosed long exposure to DMRA across tracked superinvestors is $60M as of the Jun 2026 filings.
One email when a tracked manager opens, adds to or files to sell a position — from Form 4, 13D and Form 144, not the 45-day-old 13F.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Jun 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.